Dialysis breakthrough? two simple Add-Ons may cut deadly complications
NCT ID NCT07335471
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two extra treatments for people on dialysis for kidney failure. One adds a special filter (hemoperfusion) to clean more toxins from the blood, aiming to reduce heart and brain complications. The other gives a steady sugar solution during dialysis to help patients who get dangerously low blood pressure. The trial involved 100 adults and checked if these methods improve safety and comfort during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hemoperfusion and continuous high-glucose infusion
What this could lead to
If successful, these approaches could help dialysis patients have fewer heart and brain problems, and make dialysis sessions safer and more comfortable.
What could go wrong
This is a small, single-center study with only 100 participants, so results may not apply to everyone. Risks include bleeding, infection, and blood sugar changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBROVASCULAR DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blood Purification Center, Suzhou Hospital Affiliated to Anhui Medical University
Suzhou, Anhui, 234000, China